108 related articles for article (PubMed ID: 12970211)
1. A new scoring system to determine thromboembolic risk after heart valve replacement.
Butchart EG; Ionescu A; Payne N; Giddings J; Grunkemeier GL; Fraser AG
Circulation; 2003 Sep; 108 Suppl 1():II68-74. PubMed ID: 12970211
[TBL] [Abstract][Full Text] [Related]
2. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
3. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
[TBL] [Abstract][Full Text] [Related]
4. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
5. Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve.
Baykut D; Grize L; Schindler C; Keil AS; Bernet F; Zerkowski HR
Ann Thorac Surg; 2006 Sep; 82(3):847-52. PubMed ID: 16928496
[TBL] [Abstract][Full Text] [Related]
6. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.
Jamieson WR; Fradet GJ; MacNab JS; Burr LH; Stanford EA; Janusz MT; Abel JG; Germann E; Cheung A
J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
8. Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement.
Lehmann S; Walther T; Leontjev S; Kempfert J; Rastan A; Garbade J; Borger MA; Falk V; Mohr FW
J Heart Valve Dis; 2007 Nov; 16(6):641-8; discussion 648. PubMed ID: 18095514
[TBL] [Abstract][Full Text] [Related]
9. Five-year follow up of the ATS mechanical heart valve.
Emery RW; Krogh CC; Jones DJ; Nicoloff DM; Blake DP; Arom KV
J Heart Valve Dis; 2004 Mar; 13(2):231-8. PubMed ID: 15086262
[TBL] [Abstract][Full Text] [Related]
10. North American multicenter experience with the On-X prosthetic heart valve.
McNicholas KW; Ivey TD; Metras J; Szentpetery S; Marra SW; Masters RG; Dilling EW; Slaughter MS; Mack MJ
J Heart Valve Dis; 2006 Jan; 15(1):73-8; discussion 79. PubMed ID: 16480015
[TBL] [Abstract][Full Text] [Related]
11. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
Ruel M; Kapila V; Price J; Kulik A; Burwash IG; Mesana TG
Circulation; 2006 Jul; 114(1 Suppl):I541-6. PubMed ID: 16820634
[TBL] [Abstract][Full Text] [Related]
12. Our inability to predict thromboembolic events after prosthetic valve surgery.
Will MB; Bernacca GM; Bell EF; Tolland MM; Lowe GD; Rumley A; Murray HM; Ford I; Wheatley DJ
J Heart Valve Dis; 2006 Jul; 15(4):570-80; discussion 580. PubMed ID: 16901057
[TBL] [Abstract][Full Text] [Related]
13. Performance of bioprostheses and mechanical prostheses in age group 61-70 years.
Prasongsukarn K; Jamieson WR; Lichtenstein SV
J Heart Valve Dis; 2005 Jul; 14(4):501-8, 510-1; discussion 509. PubMed ID: 16116877
[TBL] [Abstract][Full Text] [Related]
14. Update of the Providence Health System experience with the CarboMedics prosthesis.
Wu Y; Gao G; Mody S; Grunkemeier GL; Ahmad A
J Heart Valve Dis; 2006 May; 15(3):414-20. PubMed ID: 16784082
[TBL] [Abstract][Full Text] [Related]
15. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005.
Tossios P; Reber D; Oustria M; Holland-Letz T; Germing A; Buchwald D; Laczkovics A
J Heart Valve Dis; 2007 Sep; 16(5):551-7. PubMed ID: 17944128
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis.
Le Tourneau T; Marechaux S; Vincentelli A; Ennezat PV; Modine T; Polge AS; Fayad G; Prat A; Warembourg H; Deklunder G
J Heart Valve Dis; 2007 Sep; 16(5):483-8. PubMed ID: 17944119
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic events early after mitral valve repair: incidence and predictive factors.
Meurin P; Tabet JY; Iliou MC; Pierre B; Corone S; Cristofini P; Iung B; Ben Driss A;
Int J Cardiol; 2008 May; 126(1):45-52. PubMed ID: 17490763
[TBL] [Abstract][Full Text] [Related]
18. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
Mykén PS
J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
[TBL] [Abstract][Full Text] [Related]
19. [The best of valvular heart disease in 2006].
de Gevigney G;
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
